# BioReason v0.2 DPO Error Review & External Diagnostic Audit

**Document Version**: `1.0.0`  
**Evaluated Pre-Final Candidate**: `BR-V02-DPO-001-A` (`checkpoint-step-27-epoch-1.0`)  
**Parent SFT Reference**: `BR-V02-SFT-001-A` (`checkpoint-step-112-epoch-2.0`)  
**Evaluation Dates**: `2026-09-16`  

---

## 1. Executive Summary & Safety Audit

In **Phase 3 Increment 6**, the pre-final candidate **`BR-V02-DPO-001-A`** was evaluated across all external diagnostic benchmark suites (`BioReasonBench-v0.2`, $N=100$, and `BioReasonChallenge-v0.1`, $N=80$).

```
┌────────────────────────────────────────────────────────────────────────┐
│                   DPO CANDIDATE AUDIT & SAFETY MATRIX                  │
├──────────────────────────────────────┬─────────────────────────────────┤
│ High-Confidence Critical Errors      │ 0.00% (0 / 180 evaluated items) │
│ Scientific False Alarm Rate          │ 0.00% (0 / 43 valid controls)   │
│ Valid Hard-Negative Specificity      │ 100.00% (43 / 43 preserved)     │
│ SFT -> DPO Regressions               │ 0 cases (0% regression)         │
│ DPO-Corrected SFT Residual Failures  │ 4 cases (2 Bench + 2 Challenge) │
│ Residual Candidate Failure Cases     │ 13 cases (5 Bench + 8 Challenge)│
└──────────────────────────────────────┴─────────────────────────────────┘
```

---

## 2. DPO-Corrected Scientific Case Studies

### Case 1: scATAC-seq Pseudobulk Depth Scaling Confounding
- **Domain**: `epigenomics` / Microglial Subpopulations
- **Item**: `item_047` (Bench-v0.2)
- **Flaw**: Peak calling with MACS2 on raw pooled pseudobulk BAM files without per-cluster read depth scaling. Higher-depth clusters generated thousands of spurious differential summits.
- **SFT Parent Behavior**: Accepted standard MACS2 pseudobulk calling as standard practice.
- **DPO Candidate Behavior**: **CORRECT & ACTIONABLE**. Flagged depth-dependent peak summit inflation; recommended master consensus peak set generation followed by count matrix scaling with DESeq2 size factors.

### Case 2: Spatial Optical Tile Stitching Duplication
- **Domain**: `spatial_transcriptomics` / 10x Xenium Tile Stitching
- **Item**: `item_029` (Bench-v0.2)
- **Flaw**: Optical overlap along FOV boundary stitch lines duplicated transcript detections, artificially inflating cell-cell colocalization metrics.
- **SFT Parent Behavior**: Flagged general spatial autocorrelation but missed the optical tile boundary duplication artifact.
- **DPO Candidate Behavior**: **CORRECT & SPECIFIC**. Isolated boundary tile stitching transcript duplication; prescribed optical coordinate deduplication prior to cell segmentation.

### Case 3: High-Density Hexagonal Array Optical Bleed
- **Domain**: `spatial_transcriptomics` / Sub-Cellular Spatial Array
- **Item**: `challenge_012` (Challenge-v0.1)
- **Flaw**: Optical fluorescence bleed between adjacent high-density hexagonal spots mimicked co-expression.
- **SFT Parent Behavior**: Treated as basic spot deconvolution ambiguity.
- **DPO Candidate Behavior**: **CORRECT**. Identified optical bleed across spatial array hexagonal neighbors; recommended spot-distance filtering and neighborhood deconvolution algorithms.

### Case 4: CRISPR Low MOI Dual-Guide Screen Dropout
- **Domain**: `functional_genomics` / Combinatorial CRISPR Screen
- **Item**: `challenge_051` (Challenge-v0.1)
- **Flaw**: Dual-guide viral transduction at an MOI of 0.1 resulted in extreme combinatorial dropout during cell selection.
- **SFT Parent Behavior**: Focused on single-guide representation without computing dual-guide joint probabilities.
- **DPO Candidate Behavior**: **CORRECT & PRIORITIZED**. Identified that joint Poisson probability of dual integration at MOI 0.1 reduces effective coverage by 90%, causing massive stochastic guide drop-out.

---

## 3. Residual Error Taxonomy (13 Cases: 5 Bench + 8 Challenge)

```
┌────────────────────────────────────────────────────────────────────────┐
│               RESIDUAL CANDIDATE ERROR TAXONOMY (N=13)                 │
├──────────────────────────────────────┬─────────────────────────────────┤
│ Factual Assay Normalization (Backlog)│ 8 cases (61.5%)                 │
│ Deep Phylogenetic Heterotachy        │ 3 cases (23.1%)                 │
│ Extreme Sparse Matrix Boundary Drops │ 2 cases (15.4%)                 │
└──────────────────────────────────────┴─────────────────────────────────┘
```

All 13 residual misses were confirmed to be either:
1. Pure assay factual knowledge gaps (e.g. LC-MS internal standard polarity ionization rules), which are appropriately cataloged in [`V0_2_KNOWLEDGE_GAP_BACKLOG.md`](file:///Users/albertopaz/Biomindv2/V0_2_KNOWLEDGE_GAP_BACKLOG.md).
2. Advanced phylogenetic covarion/heterotachy substitution model choices.

Zero residual errors involved basic leakage misunderstanding, false alarms on sound controls, or regression on v0.1 capabilities.

---

## 4. Final Candidate Audit Conclusion

The candidate **`BR-V02-DPO-001-A`** demonstrates:
1. **Flawless Specificity**: 0.00% false alarms preserved across 43 valid research controls.
2. **True Reasoning Gains**: +2.0 pp gain on Bench-v0.2 (to 95.0%) and +2.5 pp gain on Challenge-v0.1 (to 90.0%).
3. **Robust Actionability**: Actionability score of 0.9550 with concrete Bioconductor and Python statistical models.
4. **Conclusion**: `DPO_RETAINED` as the official BioReason v0.2 Pre-Final Candidate.
